Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06349564 · ClinicalTrials.gov registry record · NA
Implementing Virtual Reality (VR) to Reduce Sedation
A NA study of Sedative During Endoscopy, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06349564 is a NA study of Sedative During Endoscopy that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06349564, a NA study of Sedative During Endoscopy, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose of this study is to assess the feasibility, effect, and safety of using VR goggles during endoscopic procedures to decrease sedation requirements, enhance patient satisfaction, and reduce recovery time.
Conditions Studied
Interventions
- DEVICE Pico 4 Enterprise headset with noise cancelling headphones
Study Locations (1)
New York
- NYU Langone Brooklyn - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-12-09 |
| Est. Completion | 2026-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06349564
The ClinicalTrials.gov registry entry for NCT06349564 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Sedative During Endoscopy appearing as the primary indexed condition, and to 1 intervention - of which Pico 4 Enterprise headset with noise cancelling headphones is the first listed.
NCT06349564 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06349564 about?
NCT06349564 is a clinical study titled "Implementing Virtual Reality (VR) to Reduce Sedation". The study is a prospective pilot patients aged 21 to 65 undergoing screening colonoscopy or diagnostic upper endoscopy. Patients are administered minimal sedation (2 mg of Versed and 25 mg of Fentanyl) and are given Virtual Reality (VR) goggles to wear for the duration of the procedure. The purpose ...
What is the current status of trial NCT06349564?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-12-09. Estimated completion is 2026-09.
What conditions does trial NCT06349564 study?
This clinical trial studies the following conditions: Sedative During Endoscopy.
What interventions are being tested in trial NCT06349564?
The interventions under investigation include: Pico 4 Enterprise headset with noise cancelling headphones (DEVICE).
Who is sponsoring clinical trial NCT06349564?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06349564 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.